Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma

Figure 3

CXC gene-based establishment of prognostic characteristics and validation of their predictive performance. (a) Kaplan-Meier survival curve to assess the prognostic value of the risk model for LUAD patients. (b) AUC of the risk model for the 1-year, 2-year, and 3-year survival prediction curves. TP represents TRUE positive, and FP is FALSE positive according to cutoff. (c and d) GSE31210 dataset (c) and GSE72094 dataset (d) used to validate the predictive performance of the risk model for survival of LUAD patients. (e) A nomogram constructed based on the risk score of the TCGA LUAD training set and the clinical characteristics of the patients.

(a)

(b)

(c)

(d)

(e)